Ultrastructural changes in rat hepatocytes following discontinuation of pregnenolone-16 alpha-carbonitrile treatment.
D000284:Administration, Oral; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus; D003593:Cytoplasm; D004721:Endoplasmic Reticulum; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D006056:Golgi Apparatus; D008099:Liver / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects*; D008112:Liver Glycogen / Q000378:metabolism; D008247:Lysosomes; D008830:Microbodies; D008854:Microscopy, Electron; D008862:Microsomes, Liver / Q000201:enzymology; D008930:Mitochondria, Liver; D009570:Nitriles; D009929:Organ Size; D011284:Pregnenolone / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats
D008112:Liver Glycogen; D009570:Nitriles; D011284:Pregnenolone